Evidence map›Paper›PMID 35416687›Full record

ArticleJournal of bacteriology2022

Pellicle Biofilm Formation in

Andrea Sass, Ian Vandenbussche, Barbara Bellich, Paola Cescutti, Tom Coenye

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Diversification of biofilm architecture among freshwaterApplied and environmental microbiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Andrea SassLaboratory of Pharmaceutical Microbiology, Ghent Universitygrid.5342.0, Ghent, Belgium.
Ian VandenbusscheLaboratory of Pharmaceutical Microbiology, Ghent Universitygrid.5342.0, Ghent, Belgium.
Barbara BellichDepartment of Life Sciences, University of Triestegrid.5133.4, Trieste, Italy.
Paola CescuttiDepartment of Life Sciences, University of Triestegrid.5133.4, Trieste, Italy.
Tom CoenyeLaboratory of Pharmaceutical Microbiology, Ghent Universitygrid.5342.0, Ghent, Belgium.ORCID 0000-0002-6407-0601
Ghent University · BEUniversity of Trieste · IT

Funding

UGent | Bijzonder Onderzoeksfonds UGent (BOF) BOFDOC2016001301
6 · The paper itself

Abstract

The chemosensory signal transduction system Wsp regulates biofilm formation and related phenotypes by influencing cyclic-di-GMP (c-di-GMP) levels in bacterial cells. This is typically achieved by activation of the diguanylate cyclase WspR, through phosphorylation of its phosphoreceiver domain. The Wsp system of Burkholderia cenocepacia J2315 is in one operon with the hybrid response regulator/histidine kinase

Indexed as

Burkholderia cenocepaciaAnti-Bacterial AgentsBacterial ProteinsBiofilmsCyclic GMPGene Expression Regulation, BacterialHistidine KinaseHumansOxygenAnti-Bacterial AgentsBacterial ProteinsCyclic GMPHistidine KinaseOxygenbiofilmBurkholderiac-di-GMPWsp

Identifiers

PMID35416687
PMCPMC9112949
OpenAlexW4223554390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.